Thanks seanc for that important distinction. Whilst I’m quietly confident that all the Phase 2 trials in NNZ-2591 will be completed without any SAE’s, it’s something that is easy to take for granted.
Side note, we will have Acadia’s Q1 earnings call around 8 May 24, followed shortly thereafter by PH results (or possibly vice versa if results drop in April).
Happy days either way…
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial, page-10
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.23 |
Change
0.080(0.50%) |
Mkt cap ! $2.074B | |||
| Open | High | Low | Value | Volume |
| $16.39 | $16.57 | $16.04 | $10.33M | 637.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1336 | $16.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.30 | 3173 | 3 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |